BioSpace News Archive

Summit Venture Studio overcomes commercialization challenges to accelerate time to market for university-originated software

FzioMed, Inc., a leading biomaterials company, is pleased to announce that Oxiplex shipments have now passed the 600,000 unit mark.

Premier Medical Laboratory Services (PMLS), an award winning molecular diagnostics laboratory, introduces Virtual Lab, an innovative COVID-19 testing solution to overcome laboratory infrastructure restrictions

Bio Nebraska announced that Evonik has been named the 2020 recipient of the Governor’s Bioscience Award, presented by Gov. Pete Ricketts.

The following quote is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response: “The FDA, along with the CDC and our state and local partners, are working to investigate two outbreaks of Shiga toxin-producing E. coli O157:H7 (STEC) illnesses. We do not know what food is causing people to get

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of investigational therapeutics for neurodegenerative and rare peripheral amyloid diseases, announced today that it will report its third quarter and first nine months of 2020 financial results on Wednesday, November 4, after the close of the U.S. financial markets. Consistent with past practice, the Company wi

Golden State Dermatology is pleased to announce Jane F. Kardashian, M.D. and her team have joined Golden State Dermatology.

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2020.

Aethlon Medical, Inc., a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, reported financial results for its second quarter ended September 30, 2020 and provided an update on recent developments.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report financial results for the third quarter 2020 after market close on Monday, November 9, 2020. Company management will host a corresponding conference call beginning at 1:30pm PT. Investors interested in listening to the conference call may do so by dialing